Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors | news.google.com • |
INOVIO to Present at Upcoming Scientific Conference | news.google.com • |
INOVIO to Present at Upcoming Scientific Conference | prnewswire.com • |
INOVIO to Present at Upcoming Scientific Conference | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -1.15 | -1.19 | -0.04 | -3.48% |
2024-05-13 | 2024-03 | -1.08 | -1.31 | -0.23 | -21.30% |
2024-03-06 | 2023-12 | -1.58 | N/A | N/A | N/A |
2023-11-09 | 2023-09 | -1.56 | -1.08 | 0.48 | 30.77% |
2023-08-09 | 2023-06 | -1.68 | -1.56 | 0.12 | 7.14% |
2023-05-10 | 2023-03 | -1.68 | -1.92 | -0.24 | -14.29% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-05-10 | RBC Capital | Upgrade | Sector Perform | Sector Perform |
2023-03-01 | RBC Capital | Upgrade | Sector Perform | |
2022-11-08 | Maxim Group | Downgrade | Buy | Hold |
2022-10-31 | B of A Securities | Downgrade | Neutral | Underperform |
2022-08-09 | RBC Capital | Upgrade | Sector Perform | |
2022-05-10 | Oppenheimer | Downgrade | Outperform | Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-05-14 | BENITO SIMON X | Director | 10.02K | Conversion of Exercise of derivative security |
2024-05-14 | DANSEY ROGER D | Director | 6.75K | Conversion of Exercise of derivative security |
2024-05-14 | HUMEAU LAURENT M | Officer | 24.34K | Conversion of Exercise of derivative security |
2024-05-14 | KIES PETER D | Chief Financial Officer | 24.74K | Conversion of Exercise of derivative security |
2024-05-14 | MILLER ANN CALBY M.D. | Director | 7.71K | Conversion of Exercise of derivative security |
2024-05-14 | SHEPARD JAY P. | Director | 7.04K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 20.07M | 8.96M | 7.49% |
2023-06-29 | Shaw D.E. & Co., Inc. | 7.60M | 3.39M | 2.84% |
2023-06-29 | Blackrock Inc. | 6.09M | 2.72M | 2.27% |
2023-06-29 | Renaissance Technologies, LLC | 5.44M | 2.43M | 2.03% |
2023-06-29 | Millennium Management Llc | 5.34M | 2.38M | 1.99% |
2023-06-29 | Jane Street Group, LLC | 3.20M | 1.43M | 1.19% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 8.26M | 3.69M | 3.08% |
2023-06-29 | Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 4.06M | 1.81M | 1.51% |
2023-06-29 | Vanguard Extended Market Index Fund | 3.35M | 1.50M | 1.25% |
2023-06-29 | Vanguard Strategic Equity Fund | 3.00M | 1.34M | 1.12% |
2023-08-30 | iShares NASDAQ Biotechnology ETF | 1.88M | 844.39K | 0.70% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.27M | 761.76K | 0.47% |
Dividend | Date |
---|---|
0.0057 | 2017-09-28 |
0.0057 | 2017-08-29 |
0.0057 | 2017-07-27 |
0.0057 | 2017-06-28 |
Split | Date |
---|---|
1 : 12 | 2024-01-25 |
1 : 4 | 2014-06-06 |
1 : 4 | 2014-06-05 |
0.25 : 1 | 2004-09-13 |
-
Lol see sell off
-
-
Watch it sell off, it’s good news.
-
History $IBIO was built for pandemic purposes in 2010 by DARPA. In 2011 the influenza disease outbreak happened and IBIO hit their peak as a company. Then the disease died out and so did their stock price. In 2014, the outbreak of Ebola happened and so they hit another peak. Now look where we’re at now.Covid is destroying the world in many ways and people are seeing how big this has effected the world so far. IBIO was built for this exact reason. In my opinion, influenza became less dangerous as scientists have developed vaccines and the spread of Ebola died out. COVID will not die for months/years to come. $IBIO shares price in past pandemics 15$-55$, $IBIO is known for FastPharming has applications far beyond producing a COVID-19 vaccine. An example of this potential was a deal signed in October with Safi Biosolutions. The agreement will see iBio’s FastPharming system used in the bioprocessing of Safi’s blood cell therapy products. FastPharming has the potential to be part of many such deals in the future. $IBIO conference is Today (there are speculation of possible contract or partnership)
-
-
Burn the shorties!! LOL
-
Get tucked
-
Lol so typical.
-
History $IBIO made money in all the pandemics, share price in pandemics was between 15$and 55$, big conference is coming, $IBIO was built for pandemic purposes in 2010 by DARPA. In 2011 the influenza disease outbreak happened and IBIO hit their peak as a company. Then the disease died out and so did their stock price. In 2014, the outbreak of Ebola happened and so they hit another peak.The spread of disease slowed and was forgotten about so the company SP went down all the way to pennies because there hasn’t been any major viruses since 2014. Now look where we’re at now.Covid is destroying the world in many ways and people are seeing how big this has effected the world so far. IBIO was built for this exact reason. In my opinion, influenza became less dangerous as scientists have developed vaccines and the spread of Ebola died out. COVID will not die for months/years to come.
-
-
-
-
-
$INO Just to let y’all know if Biden gets elected this stock is fucked. Prepare your Selves because it’s looking ugly.
-
-
Market is probably going to slide sideways and negative until about 1 week from election. Remember regardless if Trump is out of office, he’ll have fiscal influence until the 1st week of jan...expect high volatility. Purchase calls for vaccine stocks, move stake into renewables & nat gas, and portfolio will survive. For those that can’t...i am so sorry xD
-
What a pos
-
-
INOVIO to Present at Upcoming Scientific Conference
news.google.com • -
INOVIO to Present at Upcoming Scientific Conference
prnewswire.com • -
INOVIO to Present at Upcoming Scientific Conference
news.google.com • -
(INO) Proactive Strategies
news.google.com • -
Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
INOVIO Reports Inducement Grant Under Inducement Plan
prnewswire.com • -
INOVIO Reports Inducement Grant Under Inducement Plan
prnewswire.com • -
INOVIO Added to Russell 2000® Index Effective July 1, 2024
prnewswire.com • -
INOVIO Reports Inducement Grants Under Inducement Plan
prnewswire.com • -
Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript
seekingalpha.com •